Trust Point’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Trust Point's BMY Position: Q3 2026 in Review
Trust Point increased its Bristol-Myers Squibb (BMY) stake by 18% in Q3 2026, buying an estimated $160K and bringing the position to 16,441 shares worth $1.03M. The position accounts for 0.08% of the portfolio, ranked #144.
Trust Point first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Trust Point held 16,441 shares of Bristol-Myers Squibb worth $1.03M as of Q3 2026.
- Trust Point bought 2,529 Bristol-Myers Squibb shares in Q3 2026, an estimated $160K.
- Bristol-Myers Squibb made up 0.08% of Trust Point's portfolio in Q3 2026, its #144 holding.
- Trust Point first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.